Go Horiguchi
Overview
Explore the profile of Go Horiguchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
66
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ueda T, Hayakawa K, Horiguchi G, Murashita J, Shiraishi T, Fujimoto S, et al.
Prostate
. 2025 Jan;
e24855.
PMID: 39815445
Background: Differences in the effectiveness of second-generation androgen receptor axis-targeted agents (ARATs) in high-risk metastatic hormone-sensitive prostate cancer (mHSPC) remain unclear. This study aimed to identify the factors influencing the...
2.
Kawamura T, Oda Y, Toyoizumi H, Kato M, Sekiguchi M, Takamaru H, et al.
J Gastroenterol Hepatol
. 2024 Oct;
40(1):153-158.
PMID: 39478410
Background And Aim: The risk of colorectal cancer among fecal immunochemistry test-positive individuals who had undergone previous colonoscopies remains unclear. Therefore, this study aimed to determine the differences in the...
3.
Khan K, Fujishita A, Hiraki K, Ogawa K, Horiguchi G, Teramukai S, et al.
J Obstet Gynaecol Res
. 2024 Oct;
50(12):2327-2337.
PMID: 39438025
Aim: We investigated the association between the length of anogenital distance (AGD) and intra-vaginal pH, an indicator of vaginal eubiosis or dysbiosis, in women with endometriosis. Methods: A prospective cohort...
4.
Kondoh Y, Furukawa T, Hozumi H, Suda T, Egashira R, Jokoh T, et al.
BMC Pulm Med
. 2024 Oct;
24(1):511.
PMID: 39396941
Background: Multidisciplinary discussion (MDD), in which physicians, radiologists, and pathologists communicate and diagnose together, has been reported to improve diagnostic accuracy compared to diagnoses made solely by physicians. However, even...
5.
Kobayashi G, Shinozaki T, Okada H, Nakajima H, Hashimoto Y, Hamaguchi M, et al.
Diabetes Res Clin Pract
. 2024 Oct;
217:111888.
PMID: 39395467
Aims: To compare the predictive abilities of body mass index (BMI), waist circumference (WC), waist-corrected BMI (wBMI), a body shape index (ABSI), and waist-to-height ratio (WHtR) for the incidence of...
6.
Ueno M, Imai K, Tomioka Y, Horiguchi G, Kameda T, Teramukai S, et al.
Jpn J Ophthalmol
. 2024 Oct;
68(6):660-668.
PMID: 39356386
To evaluate the efficacy and safety of a cultured human corneal endothelial cell (cHCEC) product in eyes with bullous keratopathy (BK). Combined analysis of multicenter phase II and III clinical...
7.
Nakai H, Ueda K, Kitazawa K, Fukuoka H, Inatomi T, Yokoi N, et al.
Jpn J Ophthalmol
. 2024 Oct;
68(6):731-740.
PMID: 39356385
Purpose: To investigate the visual prognosis of ocular surface squamous neoplasia (OSSN) after tumor resection and ocular surface reconstruction, and clarify factors that influence recurrence. Study Design: Retrospective cohort study....
8.
Sekiguchi M, Kawamura T, Horiguchi G, Mizuguchi Y, Takamaru H, Toyoizumi H, et al.
Am J Gastroenterol
. 2024 Sep;
120(2):473-477.
PMID: 39311566
Introduction: This study investigated the detection rate of colorectal neuroendocrine neoplasms (NENs) using large-scale colonoscopy data. Methods: This cross-sectional analysis used large-scale data from a Japanese multicenter observational study of...
9.
Kitagawa A, Horiguchi G, Nomoto H, Shimizu M, Hironobu M, Ue A, et al.
J Glaucoma
. 2024 Jul;
33(11):849-854.
PMID: 39083006
Prcis: Analysis of Ambient Interactive Zippy Estimation of Sequential Testing (AIZE) Rapid test variability in patients with stable glaucoma showed that the 95% prediction interval of the mean deviation (MD)...
10.
Moriguchi M, Okuda K, Horiguchi G, Kataoka S, Seko Y, Yamaguchi K, et al.
Liver Int
. 2024 Jun;
44(8):1751-1761.
PMID: 38838097
Background And Aims: This study aimed to determine the safety and efficacy of atezolizumab + bevacizumab therapy in hepatocellular carcinoma patients receiving anti-platelet agents or anticoagulants. Methods: Patients were divided...